FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 127 filers reported holding FLEXION THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $432,000 | -28.2% | 70,956 | -3.0% | 0.00% | -50.0% |
Q2 2021 | $602,000 | -1.0% | 73,185 | +7.7% | 0.00% | 0.0% |
Q1 2021 | $608,000 | -26.8% | 67,956 | -5.6% | 0.00% | -33.3% |
Q4 2020 | $831,000 | +11.7% | 72,016 | +0.6% | 0.00% | 0.0% |
Q3 2020 | $744,000 | -20.9% | 71,556 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $940,000 | +95.0% | 71,556 | +16.7% | 0.00% | +100.0% |
Q1 2020 | $482,000 | -59.3% | 61,300 | +7.2% | 0.00% | -60.0% |
Q4 2019 | $1,183,000 | +51.1% | 57,170 | 0.0% | 0.01% | +66.7% |
Q3 2019 | $783,000 | +23.7% | 57,170 | +11.1% | 0.00% | 0.0% |
Q2 2019 | $633,000 | +7.7% | 51,473 | +9.1% | 0.00% | 0.0% |
Q1 2019 | $588,000 | +22.8% | 47,161 | +11.3% | 0.00% | 0.0% |
Q4 2018 | $479,000 | -33.2% | 42,365 | +10.4% | 0.00% | 0.0% |
Q3 2018 | $717,000 | -2.2% | 38,365 | +35.3% | 0.00% | -25.0% |
Q2 2018 | $733,000 | +13.8% | 28,365 | -1.4% | 0.00% | +33.3% |
Q1 2018 | $644,000 | -11.2% | 28,765 | -0.7% | 0.00% | -25.0% |
Q4 2017 | $725,000 | – | 28,967 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SOUTHPORT MANAGEMENT, L.L.C. | 50,000 | $748,000 | 1.50% |
Novo Holdings A/S | 950,161 | $14,224,000 | 1.49% |
GILDER GAGNON HOWE & CO LLC | 4,307,870 | $64,467,000 | 1.28% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,097,463 | $16,424,000 | 0.90% |
Monashee Investment Management LLC | 35,000 | $524,000 | 0.82% |
WALL STREET ASSOCIATES | 113,400 | $1,697,000 | 0.68% |
Convector Capital Management, LP | 24,000 | $359,000 | 0.50% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 891,274 | $13,338,000 | 0.48% |
WASATCH ADVISORS LP | 835,781 | $12,507,000 | 0.19% |
SHEPHERD KAPLAN KROCHUK, LLC | 41,755 | $625,000 | 0.16% |